Cardiology MCQs

Cardiology MCQs Which of the following is NOT a drug used for metabolic modulation in heart failure? Trimetazidine Ranolazine Perhexiline Sacubitril-valsartan Correct answer: 4. Sacubitril-valsartan Sacubitril-valsartan is an angiotensin receptor-neprilysin inhibitor (ARNI). Trimetazidine is a 3-ketoacyl coenzyme A thiolase inhibitor, while ranolazine inhibits the late sodium current. Perhexiline inhibits carnitine palmitoyl transferase. Latter three are metabolic modulators while sacubitril-valsartan is a hemodynamic modulator in heart failure [Ashrafian H, Neubauer S. Metabolic modulation in heart failure: high time for a definitive clinical trial. Heart. 2011 Feb;97(4):267-8]. Fleischner’s sign is: Prominent central pulmonary artery in acute massive pulmonary embolism Partial anomalous pulmonary venous drainage to inferior vena cava Supracardiac shadow in total anomalous pulmonary venous drainage None of the above Correct answer: 1. Prominent central pulmonary artery in acute massive pulmonary embolism [Cooksley T, Husein B, Iqbal J, Bright J. Fleischner’s sign in a massive pulmonary embolism. J Emerg Med. 2012 Jun;42(6):698-9]. Partial anomalous pulmonary venous drainage to inferior vena cava seen on chest X-ray is scimitar sign. Supracardiac shadow in total anomalous pulmonary venous drainage is known as figure of 8 sign,  cottage loaf sign and snow man appearance. Biomarker useful in the evaluation of aortic dissection: D-dimer Troponin Soluble ST2 B-type ...
Source: Cardiophile MD - Category: Cardiology Authors: Tags: Cardiology MCQ DM / DNB Cardiology Entrance Source Type: blogs